Quick Takeaways
- NPCE - NeuroPace Inc has 18 insiders with reported activity on this page.
- Net insider value flow over the last year: -$3,064,583.
- Recent transaction rows are available for direct filing-level review.
- Info
- Insider Trading
- Financials
- Holders
Insider Transactions Reported by 18 Insiders of NeuroPace Inc
- Symbol
- NPCE on Nasdaq
- Location
- Mountain View, CA
What Changed
- Buy value: ; sell value: $3,064,582.
- Net share flow: -193,136.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Source Evidence
Filed on Form 4
See Original Filing
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Insider trading overview
Last 12 monthsNet insider flow leans to selling over the last 12 months. Net value: -$3,064,583.
Buys
$0
Shares: 0
Insiders: 0
Sells
$3,064,583
Shares: 193,136
Insiders: 2
Net
-$3,064,583
Shares: -193,136
Insiders: -2
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 25,000 | $0 | $399,250 | -$399,250 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 168,136 | $0 | $2,665,333 | -$2,665,333 |
NeuroPace Inc executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Uri Geiger | Director | $66,806,045 | Mixed | 20 Mar 2026 | ||
| ORBIMED ADVISORS LLC | 10%+ Owner | $51,616,892 | -$2,665,333 | -4.9% | Filing P/S | 14 May 2025 |
| Accelmed Partners II L.P. | 10%+ Owner | $44,878,722 | Mixed | 21 Nov 2022 | ||
| Frank M. Fischer | Director | $8,939,558 | Mixed | 20 Mar 2026 | ||
| Michael Favet | Chief Executive Officer, Director | $4,121,237 | Mixed | 21 Feb 2023 | ||
| Joseph Lacob | Director | $3,579,386 | Mixed | 20 Mar 2026 | ||
| Rebecca Kuhn | Chief Financial Officer | $1,782,040 | Mixed | 03 Jun 2025 | ||
| Joel Becker | CHIEF EXECUTIVE OFFICER, Director | $1,479,258 | Mixed | 03 Mar 2026 | ||
| Irina Ridley | Chief Legal Officer/Secretary | $1,428,877 | Mixed | 20 Feb 2023 | ||
| Martha Morrell | Chief Medical Officer | $730,049 | -$399,250 | -35% | Mixed | 24 Mar 2026 |
| Patrick F. Williams | Chief Financial Officer | $646,051 | Mixed | 20 Jun 2025 | ||
| Rakhi Kumar | Director | $287,783 | Mixed | 20 Mar 2026 | ||
| KCK LTD. | 10%+ Owner | $0 | Mixed | 20 Feb 2025 | ||
| Renee Ryan | Director | Mixed | 06 Jun 2025 | |||
| Lisa Andrade | Director | Mixed | 06 Jun 2025 | |||
| R. Scott Huennekens | Director | Mixed | 06 Jun 2025 | |||
| Evan Norton | Director | Mixed | 21 Apr 2021 | |||
| Greg Shaw Garfield | Director | Mixed | 13 Jun 2022 |
Top shareholders of NeuroPace Inc (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Uri Geiger |
3/4/5
|
Director |
—
mixed-class rows
|
4,456,551
mixed-class rows
|
$66,806,045 | — | 20 Mar 2026 | |
| ORBIMED ADVISORS LLC |
3/4/5
13D/G
13F
|
10%+ Owner · Company |
8%
from 13D/G
|
3,238,199
|
$51,616,892 | -$2,665,333 | 14 May 2025 | |
| Accelmed Partners II L.P. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
4,432,948
|
$44,878,722 | — | 21 Nov 2022 | |
| Polar Capital Holdings Plc |
13F
13D/G
|
Company |
9.1%
from 13D/G
|
2,878,523
|
$44,444,395 | — | 31 Dec 2025 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
8.1%
|
2,703,208
|
$41,737,532 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
13D/G
|
Company |
8.3%
from 13D/G
|
2,547,784
|
$39,337,784 | — | 31 Dec 2025 | |
| BlackRock, Inc. |
13F
|
Company |
7.2%
|
2,383,917
|
$36,807,679 | — | 31 Dec 2025 | |
| Soleus Private Equity Fund I, L.P. |
13D/G
|
Guy Levy |
8.9%
|
2,957,957
|
$30,496,537 | $0 | 30 Sep 2025 | |
| Soleus Capital Master Fund, L.P. |
13D/G
|
Soleus Capital Management, L.P. |
7%
|
2,303,828
|
$23,545,122 | $0 | 30 Jun 2025 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
4.5%
|
1,511,289
|
$23,334,302 | — | 31 Dec 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.5%
|
1,482,228
|
$22,885,600 | — | 31 Dec 2025 | |
| First Light Asset Management, LLC |
13F
|
Company |
4.1%
|
1,349,482
|
$20,836,002 | — | 31 Dec 2025 | |
| Kent Lake PR LLC |
13D/G
|
— |
4.9%
|
1,482,555
|
$17,227,289 | +$116,944 | 31 Dec 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
2.8%
|
929,522
|
$14,351,820 | — | 31 Dec 2025 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
2.4%
|
792,000
|
$12,228,480 | — | 31 Dec 2025 | |
| Kevin Kotler |
13F
|
Individual |
1.9%
|
631,468
|
$9,749,866 | — | 31 Dec 2025 | |
| FMR LLC |
13F
|
Company |
1.9%
|
624,947
|
$9,649,182 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.8%
|
596,248
|
$9,208,225 | — | 31 Dec 2025 | |
| Frank M. Fischer |
3/4/5
|
Director |
—
mixed-class rows
|
603,922
mixed-class rows
|
$8,939,558 | — | 20 Mar 2026 | |
| STATE STREET CORP |
13F
|
Company |
1.3%
|
447,864
|
$6,915,020 | — | 31 Dec 2025 | |
| SILVERCREST ASSET MANAGEMENT GROUP LLC |
13F
|
Company |
1.2%
|
396,619
|
$6,123,797 | — | 31 Dec 2025 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
0.89%
|
295,089
|
$4,556,174 | — | 31 Dec 2025 | |
| Michael Favet |
3/4/5
|
Chief Executive Officer, Director |
—
class O/S missing
|
407,080
|
$4,121,237 | — | 21 Feb 2023 | |
| Joseph Lacob |
3/4/5
|
Director |
—
mixed-class rows
|
247,053
mixed-class rows
|
$3,579,386 | — | 20 Mar 2026 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.7%
|
231,774
|
$3,578,591 | — | 31 Dec 2025 | |
| Walleye Capital LLC |
13F
|
Company |
0.69%
|
228,847
|
$3,533,398 | — | 31 Dec 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.67%
|
222,300
|
$3,432,312 | — | 31 Dec 2025 | |
| Palumbo Wealth Management LLC |
13F
|
Company |
0.64%
|
214,175
|
$3,306,862 | — | 31 Dec 2025 | |
| ESSEX INVESTMENT MANAGEMENT CO LLC |
13F
|
Company |
0.64%
|
213,892
|
$3,302,492 | — | 31 Dec 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.6%
|
198,997
|
$3,072,514 | — | 31 Dec 2025 | |
| TUDOR INVESTMENT CORP ET AL |
13F
|
Company |
0.58%
|
193,346
|
$2,985,262 | — | 31 Dec 2025 | |
| ALGERT GLOBAL LLC |
13F
|
Company |
0.52%
|
172,926
|
$2,670,000 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.51%
|
170,439
|
$2,631,578 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.5%
|
164,710
|
$2,543,122 | — | 31 Dec 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.4%
|
131,859
|
$2,035,903 | — | 31 Dec 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.39%
|
130,926
|
$2,021,497 | — | 31 Dec 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.35%
|
117,558
|
$1,815,095 | — | 31 Dec 2025 | |
| Rebecca Kuhn |
3/4/5
|
CHIEF FINANCIAL OFFICER |
—
mixed-class rows
|
151,463
mixed-class rows
|
$1,782,040 | — | 03 Jun 2025 | |
| LAZARD ASSET MANAGEMENT LLC |
13F
|
Company |
0.34%
|
113,227
|
$1,748,225 | — | 31 Dec 2025 | |
| Joel Becker |
3/4/5
|
CHIEF EXECUTIVE OFFICER, Director |
—
mixed-class rows
|
196,137
mixed-class rows
|
$1,479,258 | — | 03 Mar 2026 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.28%
|
93,735
|
$1,447,268 | — | 31 Dec 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.28%
|
92,784
|
$1,432,585 | — | 31 Dec 2025 | |
| Irina Ridley |
3/4/5
|
Chief Legal Officer/Secretary |
—
class O/S missing
|
141,139
|
$1,428,877 | — | 20 Feb 2023 | |
| SEI INVESTMENTS CO |
13F
|
Company |
0.24%
|
80,243
|
$1,238,952 | — | 31 Dec 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.23%
|
76,153
|
$1,175,802 | — | 31 Dec 2025 | |
| Informed Momentum Co LLC |
13F
|
Company |
0.23%
|
75,800
|
$1,170,352 | — | 31 Dec 2025 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.22%
|
73,692
|
$1,137,812 | — | 31 Dec 2025 | |
| Legato Capital Management LLC |
13F
|
Company |
0.21%
|
69,165
|
$1,067,908 | — | 31 Dec 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.21%
|
68,555
|
$1,058,490 | — | 31 Dec 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.2%
|
68,092
|
$1,051,340 | — | 31 Dec 2025 |
Recent Insider Transactions by Companies or Individuals for NeuroPace Inc
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Martha Morrell | NPCE | Common Stock | Tax liability | -2.76% | -1,341 | 47,283 | 24 Mar 2026 | Direct | ||
| Uri Geiger | NPCE | Common Stock | Award | 6.55% | 913 | 14,858 | 20 Mar 2026 | Direct | ||
| Joseph Lacob | NPCE | Common Stock | Award | 6.23% | 865 | 14,754 | 20 Mar 2026 | Direct | ||
| Rakhi Kumar | NPCE | Common Stock | Award | 6.4% | 1,153 | 19,160 | 20 Mar 2026 | Direct | ||
| Frank M. Fischer | NPCE | Common Stock | Award | 0.31% | 1,826 | 595,177 | 20 Mar 2026 | Direct | ||
| Martha Morrell | NPCE | Common Stock | Tax liability | -2.68% | -1,340 | 48,624 | 03 Mar 2026 | Direct | ||
| Joel Becker | NPCE | Common Stock | Tax liability | -4.93% | -5,023 | 96,937 | 03 Mar 2026 | Direct | ||
| Joel Becker | NPCE | Common Stock | Tax liability | -1.09% | -1,126 | 101,960 | 27 Feb 2026 | Direct | ||
| Martha Morrell | NPCE | Common Stock | Tax liability | -0.48% | -358 | 74,964 | 27 Feb 2026 | Direct | ||
| Martha Morrell | NPCE | Common Stock | Tax liability | -4.33% | -3,412 | 75,322 | 20 Feb 2026 | Direct | ||
| Joseph Lacob | NPCE | Common Stock | Award | 5.13% | 678 | 13,889 | 19 Dec 2025 | Direct | ||
| Rakhi Kumar | NPCE | Common Stock | Award | 5.29% | 904 | 18,007 | 19 Dec 2025 | Direct | ||
| Uri Geiger | NPCE | Common Stock | Award | 5.4% | 715 | 13,945 | 19 Dec 2025 | Direct | ||
| Frank M. Fischer | NPCE | Common Stock | Award | 0.24% | 1,431 | 593,351 | 19 Dec 2025 | Direct | ||
| Martha Morrell | NPCE | Common Stock | Sale | -33.4% | $399,250 | $15.97 | -25,000 | 49,964 | 15 Dec 2025 | Direct |
| Martha Morrell | NPCE | Common Stock | Tax liability | -1.67% | -1,338 | 78,734 | 03 Dec 2025 | Direct | ||
| Joel Becker | NPCE | Common Stock | Tax liability | -1.08% | -1,126 | 103,086 | 27 Nov 2025 | Direct | ||
| Martha Morrell | NPCE | Common Stock | Tax liability | -0.44% | -357 | 80,072 | 27 Nov 2025 | Direct | ||
| Martha Morrell | NPCE | Common Stock | Tax liability | -3.65% | -3,051 | 80,429 | 20 Nov 2025 | Direct | ||
| Uri Geiger | NPCE | Common Stock | Award | 9.92% | 1,194 | 13,230 | 19 Sep 2025 | Direct | ||
| Joseph Lacob | NPCE | Common Stock | Award | 9.36% | 1,131 | 13,211 | 19 Sep 2025 | Direct | ||
| Rakhi Kumar | NPCE | Common Stock | Award | 9.68% | 1,509 | 17,103 | 19 Sep 2025 | Direct | ||
| Frank M. Fischer | NPCE | Common Stock | Award | 0.41% | 2,389 | 591,920 | 19 Sep 2025 | Direct | ||
| Martha Morrell | NPCE | Common Stock | Tax liability | -1.58% | -1,337 | 83,480 | 03 Sep 2025 | Direct | ||
| Joel Becker | NPCE | Common Stock | Tax liability | -1.07% | -1,126 | 104,212 | 27 Aug 2025 | Direct | ||
| Martha Morrell | NPCE | Common Stock | Tax liability | -0.42% | -357 | 84,817 | 27 Aug 2025 | Direct | ||
| Martha Morrell | NPCE | Common Stock | Tax liability | -3.46% | -3,052 | 85,174 | 20 Aug 2025 | Direct | ||
| Uri Geiger | NPCE | Common Stock | Award | 10.5% | 1,140 | 12,036 | 21 Jun 2025 | Direct | ||
| Rakhi Kumar | NPCE | Common Stock | Award | 10.2% | 1,440 | 15,594 | 21 Jun 2025 | Direct | ||
| Joseph Lacob | NPCE | Common Stock | Award | 9.82% | 1,080 | 12,080 | 21 Jun 2025 | Direct | ||
| Frank M. Fischer | NPCE | Common Stock | Award | 0.39% | 2,281 | 589,531 | 21 Jun 2025 | Direct | ||
| Patrick F. Williams | NPCE | Common Stock | Award | 51,850 | 51,850 | 20 Jun 2025 | Direct | |||
| Patrick F. Williams | NPCE | Stock Option (Right to Buy) | Award | 87,950 | 87,950 | 20 Jun 2025 | Direct | |||
| Renee Ryan | NPCE | Stock Option (right to buy) | Award | 8,745 | 8,745 | 06 Jun 2025 | Direct | |||
| Joseph Lacob | NPCE | Stock Option (right to buy) | Award | 8,745 | 8,745 | 06 Jun 2025 | Direct | |||
| Rakhi Kumar | NPCE | Stock Option (right to buy) | Award | 8,745 | 8,745 | 06 Jun 2025 | Direct | |||
| R. Scott Huennekens | NPCE | Stock Option (right to buy) | Award | 8,745 | 8,745 | 06 Jun 2025 | Direct | |||
| Uri Geiger | NPCE | Stock Option (right to buy) | Award | 8,745 | 8,745 | 06 Jun 2025 | Direct | |||
| Frank M. Fischer | NPCE | Stock Option (right to buy) | Award | 8,745 | 8,745 | 06 Jun 2025 | Direct | |||
| Lisa Andrade | NPCE | Stock Option (right to buy) | Award | 8,745 | 8,745 | 06 Jun 2025 | Direct | |||
| Rebecca Kuhn | NPCE | Common Stock | Tax liability | -1.01% | -1,337 | 131,613 | 03 Jun 2025 | Direct | ||
| Martha Morrell | NPCE | Common Stock | Tax liability | -1.53% | -1,338 | 85,943 | 03 Jun 2025 | Direct | ||
| Joel Becker | NPCE | Common Stock | Tax liability | -1.06% | -1,126 | 105,338 | 27 May 2025 | Direct | ||
| Rebecca Kuhn | NPCE | Common Stock | Tax liability | -0.27% | -357 | 132,950 | 27 May 2025 | Direct | ||
| Martha Morrell | NPCE | Common Stock | Tax liability | -0.41% | -357 | 87,281 | 27 May 2025 | Direct | ||
| Rebecca Kuhn | NPCE | Common Stock | Tax liability | -2.24% | -3,051 | 133,307 | 20 May 2025 | Direct | ||
| Martha Morrell | NPCE | Common Stock | Tax liability | -3.36% | -3,051 | 87,638 | 20 May 2025 | Direct | ||
| Orbimed Advisors Llc | NPCE | Common Stock | Sale | -4.94% | $2,665,333 | $15.85 | -168,136 | 3,238,199 | 14 May 2025 | See Footnotes |
| Rebecca Kuhn | NPCE | Common Stock | Tax liability | -0.17% | -237 | 136,358 | 22 Apr 2025 | Direct | ||
| Martha Morrell | NPCE | Common Stock | Tax liability | -0.26% | -237 | 90,689 | 22 Apr 2025 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.